Venturelab
close

Leading technology for organoid cultures

SUN bioscience SA

Swiss Startup - SUN bioscience Profile Main Image
Incorporated
28.01.2016
Headquarters
Lausanne
Support

Standardized cultures of stem cell-derived organoids, which are self-organizing 3D miniature tissues with organ-mimicking functions. The technology opens the door to personalized medicine, which means more effective treatments and fewer side effects than the current “one drug fits all” principle.
SUN bioscience launched a clinical pilot to determine the efficacy of available medications on intestinal organoids grown from patients suffering from Cystic Fibrosis.

News

22.01.2024

DOPPL and Rea Diagnostics get FIT Funding Boost (startupticker.ch)

28.11.2022

Growth support for pioneers (startupticker.ch)

17.09.2020

SUN Bioscience wins 27th Prix Strategis (startupticker.ch)

09.12.2019

Prix Strategis reveals the semi-finalists (startupticker.ch)

05.02.2019

SUN Bioscience selected for StartLab Incubator (startupticker.ch)

10.12.2018

Opening the door to personalized medicine (startupticker.ch)

Show all
Swiss Startup - SUN bioscience Product Image Swiss Startup - SUN bioscience Additional Image

Videos and Presentations

Watch Sylke's first ever pitch at EPFL Seed Night 2015

venture leaders in Life Sciences Boston: meet Sylke from SUN bioscience

Startup Champions: venture leaders USA 2016 kick-off event (April 21st, 2016, EPFL)